alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 11**  **- 1**  **774**

KAREN KELLY, on Behalf of Joanne Coggins, pro se , Plaintiff

- Appellant ,

v.
UNIVERSITY HEALTH SYSTEMS; DUPLIN GENERAL HOSPITAL , Defendant s - Appellee s .

App eal from the United States District Court for the Eastern District of North Carolina , at Wilmington

. Louise W. Flanagan , District Judge. ( 7 :11

- cv - 000 2 4

- FL )

Submitted : November 17, 2011 Decided: November 22, 2011

Before KING, DAVIS, and WYNN , Circu it Judges.

Affirmed by un published per curiam opinion

.

Karen Kelly , Appellant Pro Se. John D. Martin, Carolyn Pratt, CRANFILL, SUMNER & HARTZOG, LLP, Wilmington, North Carolina , for Appellee s .
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Karen Kelly, on b ehalf of Joanne Coggins, appeals the
district court ’ s order denying her motion for leave to amend and for appointment of counsel , which were filed in her underlying Emergency Medical Treatment and Active Labor Act ac tion. We
have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district

court. Kelly v. Univ. Health Sys. , No. 7:11

- cv - 00024

- FL
(E.D.N.C. June 21, 2011) . We dispense with oral argument
because the f acts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
----

**EXHIBIT        32** 

  

**Certification        Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

| (1) | The                  Report fully complies with the requirements of Section 13(a) or                  15(d) of                  the Securities Exchange Act of 1934;                  and |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The                  information contained in this Report fairly presents, in all material                  respects, the financial condition and results of operations of                  the                  Company. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | NOVEMBER                19, 2007 |                                                    |
|--------|----------------------------------|---------------------------------------------------------|
|   |                             |                                                    |
|   |                             | /s/                MICHAEL GOLDBERG                     |
|   |                             | MICHAEL                GOLDBERG                         |
|   |                             | ACTING                CHIEF EXECUTIVE OFFICER           |
|   |                             | (PRINCIPAL              EXECUTIVE OFFICER AND PRINCIPAL |
|   |                             |  FINANCIAL                AND ACCOUNTING OFFICER)  |
Exhibit 32.1

                     Pinecrest Services, Inc.

                 CERTIFICATION OF PERIODIC REPORT
    Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
                      18 U.S.C. Section 1350

The undersigned officer of Pinecrest Services, Inc. certifies pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 that:

..     the annual report on Form 10-KSB of the Company for the year ended
      December 31, 2004, fully complies with the requirements of Section 13(a)
      or 15(d) of the Securities Exchange Act of 1934; and

..     the information contained in the Form 10-KSB fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.



Date:   March 24, 2005
                                    /s/ April L. Marino
                                   _________________________________________
                                   April L. Marino
                                   Principal Executive and Financial Officer
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Derek Ward, the President, Secretary, Treasurer, Chief Executive Officer and Chief Financial Officer of Empirical Ventures, Inc. (the Company), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: (i)the Quarterly Report on Form 10-QSB of the Company, for the quarter  ended March 31, 2008, and to which this certification is attached as Exhibit 32 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  By:/s/Derek WardName:Derek WardTitle:Chief Executive Officer and ChiefFinancial OfficerDate:May 15, 2008 A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form 10-QSB to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 10-QSB), irrespective of any general incorporation language contained in such filing.
STATE of Louisiana v. Wilbert GREEN

NO. 2019-KK-0646

Supreme Court of Louisiana.

April 29, 2019

Stay denied. Writ denied.
Exhibit 4.1

 



Synergy   Pharmaceuticals INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE Inc.   CUSIP 871639 30 8 SEE REVERSE FOR CERTAIN DEFINITIONS I I • 1 I J I r   "-<' I " "tl :;J=: FULLY-PAID AND NONASSESSABLE SHARES OF   THE COMMON STOCK, $0.0001 PAR VALUE, OF Jc> m,.... h b b "tl :J:   )> en ..... ;>; ..... :IJ 0 ("") Jz> e..n., m _:IJ z   President ''" ·'" "" I ?§ "" )S: "'"   "'"" ' :ss: r 


    




 









 



Synergy   Pharmaceuticals Inc. The Corporation will furnish to any stockholder, upon   request without charge, a full statement of the powers, designations,   preferences and relative, participating, optional or other special rights of   each class of stock or series thereof and the qualification s, limitations or   restrictions of such preferences and/or rights. The following abbreviations,   when used in the inscription on the face of this certificate, s hall be   construed as though they were written out in full according to applicable law   s or regularion s: UNIF GIFT MIN ACT-Custodian _ TEN COM TEN ENT JTTEN - as   tenants in common - as tenants by the entireties -as joint tenants with right   of survivorship and not as tenants in common (Cust) (Minor) under Uniform Gifts   to Minors Act-------------------­ (State) Additional abbreviations may also   be used though not in the above list. For value received, hereby sell, assign   and transfer unto PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER   OF ASSIGNEE Please print or typewrite names and address including postal zip   code of assignee Shares of the Common Stock represented by the within   Certificate, and do hereby constitute and appoint Attomey to transfer the   said stock on the books of the within-named Corporation with full power of   substitution in the premises. Dated SIGNATURE Signature(s) Guaranteed: THE   SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION, (BANKS,   STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP   IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C.RULE   17Ad 15.
David A. DE COSTER, Appellant/Petitioner(s), v. The BANK OF NEW YORK MELLON f/kia the Bank of New York, Appellee/Respondent(s).

CASE NO.:2D18-0571

District Court of Appeal of Florida, Second District.

April 03, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
```

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Con. Res. 1 Agreed to Senate (ATS)]

<DOC>

119th CONGRESS
  1st Session
S. CON. RES. 1

 Extending the life of the Joint Congressional Committee on Inaugural 
                              Ceremonies.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 3, 2025

  Mr. Thune submitted the following concurrent resolution; which was 
                        considered and agreed to

_______________________________________________________________________

                         CONCURRENT RESOLUTION

 
 Extending the life of the Joint Congressional Committee on Inaugural 
                              Ceremonies.

    Resolved by the Senate (the House of Representatives concurring),

SECTION 1. REAUTHORIZATION OF JOINT COMMITTEE.

    Effective from January 3, 2025, the joint committee created by 
Senate Concurrent Resolution 34 (118th Congress), to make the necessary 
arrangements for the inauguration of the President-elect and the Vice 
President-elect of the United States, is continued with the same power 
and authority provided for in that resolution.

SEC. 2. USE OF CAPITOL.

    Effective from January 3, 2025, the provisions of Senate Concurrent 
Resolution 35 (118th Congress), to authorize the use of the rotunda and 
Emancipation Hall of the Capitol by the Joint Congressional Committee 
on Inaugural Ceremonies in connection with the proceedings and 
ceremonies conducted for the inauguration of the President-elect and 
the Vice President-elect of the United States are continued with the 
same power and authority provided for in that resolution.
                                 <all>
```
EX PARTE Lee EAKINS

1160987

Supreme Court of Alabama.

September 15, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Cert. denied.
EX PARTE SEALED CASE

(In re Sealed Case)

CR-15-0997

Court of Criminal Appeals of Alabama.

December 6, 2017

Mand. pet. granted.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         January 16, 2025.                    

# FOR FURTHER INFORMATION CONTACT:

Sean C. Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on January 6, 2025, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail Express, Priority Mail & USPS Ground Advantage® Contract 1249 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2025-1066, K2025-1065.                

Sean C. Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2025-00875 Filed 1-15-25; 8:45 am]

BILLING CODE 7710-12-P
TRINITY HEALTH CORPORATION, BayCare Health System, Inc., et al., Appellant/Petitioner(s), v. Susan SANDERS, Appellee/Responden(s).

CASE NO.: 2D18-4334

District Court of Appeal of Florida, Second District.

March 29, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Steven KOPSON, Appellant, v. STATE of Florida, Appellee.

No. 4D18-2942

District Court of Appeal of Florida, Fourth District.

[April 4, 2019]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
---

Exhibit 13.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the annual report on Form 20-F of Battle Mountain Gold Inc. (the “Company”) for the year ended October 31, 2014, as filed with the Securities and Exchange Commission on the date hereof, I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1.       The annual report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and 2.       The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 25, 2015 “Chet Idziszek”Chet IdziszekPresident and Chief Executive Officer E-13.1


---
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,  
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-QSB of Hemobiotech, Inc. (the "Company") for the period ended September 30, 2005, as filed with the Securities and Exchange Commission on the date hereof (the "Report"),
the undersigned, Mark J. Rosenblum, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

|a. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                  
|------------------------------------------------------------------------------------------------------------------------------------------
|                                                                                                                                          
|b. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
|Company.                                                                                                                                  

|                        |  | /s/ Mark J. Rosenblum                        | 
|----------------------- |  | -------------------------------------------- | 
|                       
|                       
|                        |  |                                              | 
|                       
|Date: November 14, 2005 |  | Mark J. Rosenblum                            | 
|                        |  | Chief Financial Officer                      | 
|                        |  | (Principal Financial and Accounting Officer) | 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon
request.

---
```

[Federal Register Volume 90, Number 12 (Tuesday, January 21, 2025)]
[Notices]
[Pages 7173-7174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01347]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1474]

Bulk Manufacturer of Controlled Substances Application: Invizyne 
Technologies, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Invizyne Technologies, Inc. has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
March 24, 2025. Such persons may also file a written request for a 
hearing on the application on or before March 24, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be

[[Page 7174]]

aware that submitted comments are not instantaneously available for 
public view on https://www.regulations.gov. If you have received a 
Comment Tracking Number, your comment has been successfully submitted 
and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 14, 2024, Invizyne Technologies, Inc., 750 
Royal Oaks Drive, Suite 106, Monrovia, California 91016-6357 applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................    7370  I
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substance for the internal use intermediates or for sale to its 
customers. In reference to drug code 7370 (Tetrahydrocannabinols), the 
company plans to bulk manufacture this drug as synthetic. No other 
activity for this drug code is authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-01347 Filed 1-17-25; 8:45 am]
BILLING CODE P
```
In connection with the Quarterly Report of Europa Trade Agency Ltd. (the "Company") on Form 10-QSB for the quarter ended April 30, 2005, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:				(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and				(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.				Dated: June 10, 2005/s/ Thomas Lamb				Thomas Lamb, President, Secretary,				Treasurer and Director

```

```
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 19
- 0 365 STATE OF MONTANA,

Plaintiff and Appellee, v. MONTE BLAIN GOSSARD ,

Defendant and Appellant.

**ORDER** Upon consideration of Appellant’s motion for extension of time, and good cause appearing, IT IS HEREBY ORDERED that Appellant is granted an extension of time to and including December 14 , 20 20 , within which to prepare, file, and serve Appellant’s opening brief on appeal.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

November 4 2020

11/04/2020

Case Number: DA 19-0365
----

| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|-----|-----------------------------------------------------------------------------------------------------------------------|

| (2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| November 15, 2010 |   |                                                                                                      |   |
|-------------------|--------|-----------------------------------------------------------------------------------------------------------|--------|
|              |   |                                                                                                      |   |
|              |   | /s/ MICHAEL GOLDBERG                                                                                 |   |
|              |   | MICHAEL GOLDBERG                                                                                          |   |
|              |   | ACTING CHIEF EXECUTIVE OFFICER(PRINCIPAL EXECUTIVE OFFICER AND PRINCIPALFINANCIAL AND ACCOUNTING OFFICER) |
Dale CULVER, Appellant, v. WELLS FARGO BANK, N.A., Appellee.

No. 4D17-3947

District Court of Appeal of Florida, Fourth District.

[April 11, 2019]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Terry Gene BOLLEA, Appellant/Petitioner(s), v. Linda Marie BOLLEA, Appellee/Respondent(s).

CASE NO.: 2D19-1049

District Court of Appeal of Florida, Second District.

April 25, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
|Exhibit 32.1
|------------

Certification Pursuant to18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Sound Revolution Inc. (the Company) on Form 10-QSB for the period ended November 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Robin Ram, Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|1 | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                               
|- | ----------------------------------------------------------------------------------------------------------------------------------------------------
| 
|2 | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| 



|Dated: January 21, 2008
|-----------------------

|By: |  | /s/ Robin Ram                               
|--- |  | --------------------------------------------
|    |  | Robin Ram                                   
|    |  | Director, President, Chief Executive Officer

---